TABLE 2:

Clinical data and results of sclerotherapy in group B

Group B	Age (y)/Sex	First Aspirates (ml)	Infused Ethanol (ml)	Ethanol Mixed Aspirates	Total Procedure (min)	First Follow-up Ultrasonography (mo)	Therapeutic Result	Complication
1	50/F	6	5	5	30	1	+
2	46/F	2	2	6	32	24	+	Mild pain and intracystic hemorrhage
3	32/F	3.5	3	3.5	27	24	+
4	31/F	2	2	2	28	2	+
5	35/F	9	9	9	30	24	+
6	60/F	2	2	3	33	1	+	Mild pain and intracystic hemorrhage
7	32/F	2	1.5	2	26	2	+
8	24/F	8	5	7	30	1	−	Mild pain
9	66/F	2	2	2	31	1	+	Mild pain
10	74/F	2	2	2	28	8	+
11	41/F	4	4	6	29	2	+	Intracystic hemorrhage
12	45/M	5	5	5	27	3	+
13	31/F	8	6	8	32	1	+	Mild pain
14	42/F	5	5	6	30	3	+	Intracystic hemorrhage
15	32/F	4	4	4	28	6	+
16	60/F	8	9	7	30	3	+
17	43/F	2	2	1.2	29	4	+
18	66/F	20	12	7	33	1	+
19	37/F	25	20	20	31	2	+	Drunken sense
20	55/M	4	4	4	27	2	+
21	46/F	4	4	2	33	1	+	Mild dizziness
22	20/F	1	1.5	1	32	5	+	Mild pain and facial flushing
23	49/F	4	4	3.5	28	1	+
24	29/F	1	1	1.2	30	1	+	Mild pain
25	41/M	5	5	2	36	1	+	Moderate pain and perithyroidal leakage
26	47/F	17	10	12	34	1	−	Intracystic hemorrhage
27	66/F	4	4	4.5	31	3	+	Intracystic hemorrhage
28	43/F	1	1	1	30	1	+
29	41/F	8	8	6.5	34	2	+	Mild pain
30	75/M	50	20	22	38	1	+	Mild pain and intracystic hemorrhage
Mean	45.3	7.3	5.4	5.5	30.6	4.4

Note.—+ indicates complete disappearance of the cystic portion of the thyroid nodule; −, incomplete disappearance of the cystic portion of the thyroid nodule.